MARKET WIRE NEWS

AMA: AI Usage Among Doctors Doubles as Confidence in Technology Grows

MWN-AI** Summary

A recent survey conducted by the American Medical Association’s Center for Digital Health and AI reveals a significant surge in the adoption of augmented intelligence (AI) among physicians in the United States, with the usage rate soaring from 38% in 2023 to an impressive 81% in 2026. This increase reflects a growing confidence in AI's clinical benefits, particularly its ability to alleviate burnout and enhance patient care. The comprehensive annual survey, which has been tracking these trends since 2023, highlights that physicians harness AI primarily for medical research summarization and clinical care documentation, averaging 2.3 AI applications per doctor as of 2026.

The study indicates a cautious yet optimistic view among physicians, with over 75% believing AI enhances their patient care capabilities, particularly in improving diagnostic accuracy and operational efficiency. However, concerns persist about patient engagement with AI—many physicians worry about the interpretation of complex medical results without professional guidance, with nearly half opposed to patients using AI for acute analyses like radiology or pathology.

The AMA emphasizes the necessity of ensuring that AI tools are safe, effective, and responsible to gain physician trust. Data privacy and robust validation of AI's safety and efficacy are pivotal for broader acceptance, with 86% and 88% of physicians highlighting these points, respectively. Moreover, 85% express a desire to be directly involved in AI adoption decisions within their practices.

The ongoing efforts of the AMA Center for Digital Health and AI aim to shape the responsible integration of AI in medicine, ensuring that it supports physicians rather than supersedes them. This commitment to patient safety and ethical practices underscores the AMA's leadership in advancing AI technology in healthcare.

MWN-AI** Analysis

The latest findings from the American Medical Association (AMA) indicate a significant surge in the adoption of artificial intelligence (AI) among physicians, with usage rates more than doubling from 38% in 2023 to 81% in 2026. This paradigm shift signals an evolving landscape in healthcare, making it crucial for stakeholders to understand the implications for investment, innovation, and market positioning.

Physicians report enhancements in clinical decision-making and reduced administrative burdens, as AI applications deepen in areas such as medical research and documentation. This expansion represents not only a new revenue stream for technology firms but also an opportunity for healthcare providers to refine their service offerings. Companies that develop AI solutions focused on safety, efficacy, and user-friendliness are likely to gain considerable traction in this growing market.

Investor sentiment should consider the cautious optimism among doctors, with over three-quarters acknowledging improved patient care capabilities. However, concerns remain around patient privacy, the potential for skill erosion, and the integrity of the doctor-patient relationship, which can impact AI acceptance and usage. Companies that prioritize transparency and regulatory compliance will likely build more robust partnerships with healthcare providers, mitigating risks associated with adoption.

Moreover, the AMA emphasizes a collaborative approach to AI integration, suggesting that solutions developed with input from healthcare professionals are more likely to succeed. This presents an avenue for startups and tech companies: engaging healthcare professionals in the development process could yield innovative applications, tailored to address specific challenges faced in practice.

In conclusion, as AI solidifies its role in healthcare, investment opportunities will emerge for companies aligning with the AMA's vision of responsible AI deployment. Stakeholders should remain vigilant of the evolving regulatory landscape and focus on solutions that respect physician autonomy while enhancing patient care outcomes.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

CHICAGO, March 12, 2026 (GLOBE NEWSWIRE) -- New research from the American Medical Association’s Center for Digital Health and AI shows that physicians’ adoption of augmented intelligence (AI) continues to grow as confidence builds in the technology’s clinical advantages.

An annual survey since 2023, the Physician Survey on Augmented Intelligence assesses adoption, perceptions, and anticipated impacts of AI in medical practice. The 2026 results found more than four in five physicians (81 percent) use AI in their practices, more than double the 2023 rate (38 percent). Physicians are cautiously optimistic about the promise of AI – including its potential to combat burnout – but they also have concern about patients using the technology to interpret complicated results without the assistance of a physician.

“AI has quickly become part of everyday medical practice. Physicians see real promise in its ability to support clinical decisions and cut down on administrative burden. But as this technology advances, it is critical that augmented intelligence be designed to enhance – not replace – physicians.” said AMA CEO John Whyte, MD, MPH. “For doctors to trust and use these tools, they must be safe, effective, and used responsibly so they truly improve patient care. The AMA will continue leading this work so physicians help shape how AI is integrated into medicine.”

Key findings from the research that illustrate the current state of physician adoption, perspectives, and uses of AI include:

Physician Use of AI

  • Clinical use of AI continues to grow in both prevalence and scope. Over 80 percent of physicians now use AI professionally, doubling since 2023. The average number of use cases per physician is 2.3 in 2026, up from 1.1 in 2023.
  • The most common physician uses of AI are centered on medical research summarization and clinical care documentation.


Perception of AI’s Impact

  • Physician confidence in AI continues to grow. In 2026, more than three-quarters of physicians believe AI improves their ability to care for patients, up from 65 percent in 2023. The greatest expected advantages are in diagnostic accuracy and work efficiency.
  • Cautious optimism remains. Forty percent of physicians have balanced attitudes that are equally excited and concerned about AI, citing patient privacy and the integrity of the patient-physician relationship as top concerns.
  • Seventy percent of physicians see AI as a tool to automate tasks that contribute to work-related burnout. However, 88 percent are concerned about potential skill loss, particularly among those with 10 years or less in practice.

Views on Patient Use of AI

  • Physicians generally support patient use of AI for general health and medication questions, but most are wary of patient use for tasks requiring clinical judgment. Nearly half strongly oppose patients using AI to interpret radiology or pathology results.


Catalysts and Barriers to AI Adoption

  • Physicians emphasize the importance of data privacy (86 percent) and robust safety and efficacy validation (88 percent) as critical for broader AI adoption. Clear liability frameworks rank highest among regulatory actions essential to build physician trust and increase adoption of AI tools.
  • Shared ownership of AI adoption decisions is a physician priority. Most physicians (85 percent) want to be consulted or directly involved in decisions about AI adoption.
  • Strong clinical evidence and practical implementation guides are the most cited support resources for successful AI integration.


The work of the AMA’s Center for Digital Health and AI continues to support physician leadership in shaping, guiding, and implementing technologies transforming medicine. Through its ongoing work, The Center advocates for the development of high-quality, clinically validated AI that is deployed in a responsible, ethical, and transparent manner with patient safety being the first and foremost concern.

Learn more about AI resources offered by the AMA by visiting the AMA STEPS Forward collection of digital health solutions, providing physicians with insights on integrating AI into workflows, establishing an AI governance framework, reducing documentation burden with AI, and navigating AI technology in health care.


AMA Media & EditorialAmerican Medical Association 312-464-4430media@ama-assn.org

FAQ**

How might the increasing adoption of AI among physicians, as highlighted in the American Medical Association’s findings, impact investment opportunities in companies like Arlington Asset Investment Corp Class A AI that focus on AI technologies in healthcare?

The increasing adoption of AI among physicians, as noted by the American Medical Association, may create robust investment opportunities in companies like Arlington Asset Investment Corp Class A AI, as demand for innovative AI healthcare solutions is expected to rise significantly.

Given that 81% of physicians now use AI, how could Arlington Asset Investment Corp Class A AI potentially benefit from this trend, particularly in relation to AI tools aimed at enhancing clinical decision-making?

Arlington Asset Investment Corp Class A AI could capitalize on the 81% physician adoption of AI by investing in or developing AI tools that enhance clinical decision-making, thereby increasing demand for such technologies and potentially driving growth and profitability in healthcare investments.

What strategies might Arlington Asset Investment Corp Class A AI implement to address physicians' concerns about data privacy and the integrity of the patient-physician relationship as AI adoption grows in medical practice?

Arlington Asset Investment Corp Class A AI could implement strategies such as enhancing data encryption, establishing clear data usage protocols, providing transparent AI decision-making processes, and fostering ongoing dialogue with physicians to build trust in AI technologies.

Considering that most physicians wish to be involved in AI adoption decisions, how could Arlington Asset Investment Corp Class A AI engage with healthcare professionals to ensure their products align with physicians’ needs and concerns?

Arlington Asset Investment Corp Class A AI could engage healthcare professionals by conducting regular consultations, gathering feedback through surveys, and forming advisory panels to ensure their AI products are tailored to physicians' needs and address their concerns effectively.

**MWN-AI FAQ is based on asking OpenAI questions about Arlington Asset Investment Corp Class A (NYSE: AI).

Arlington Asset Investment Corp Class A

NASDAQ: AI

AI Trading

-1.95% G/L:

$8.795 Last:

1,794,155 Volume:

$8.93 Open:

mwn-link-x Ad 300

AI Latest News

March 10, 2026 03:04:00 am
Consider This AI Agent Stock Over C3.ai

AI Stock Data

$1,633,441,826
111,476,599
0.22%
128
N/A
Software & IT Services
Technology
US
Redwood City

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App